[GRAPHICAL VERSION] [繁體版] [簡體版] [SEARCH] [SITE MAP] [CONTACT US ]
The vaccination comprises a single injection administered from the age of 18 months onwards. The vaccine confers protection after 7 to 14 days. It gives 3 years post-vaccine immunity. In children it only gives 2 years immunity. Do not vaccinate children under 18 months except during periods of epidemic.
Presently there are two preparations on the market - the bivalent and the quadrivalent. The bivalent vaccine is intended for the prevention of cerebrospinal meningitis caused by meningococci serogroups A and C. The quadrivalent vaccine can afford additional protection against meningococci serogroups W135 and Y.
Vaccination is recommended for:
In addition, sporadic cases of meningococcal disease are known to occur in some countries in schools, colleges, travel resorts, military barracks and other places where large numbers of adolescents and young adults congregate. Travellers should seek professional advice from doctors for vaccination in view of the individual's age and health condition, and details of the journey such as place, duration and nature.
They are usually mild or infrequent, consisting of localised redness lasting 1 to 2 days. Up to 2% of children may have fever transiently after vaccination.
The vaccine should not be administered to patients with acute infectious diseases. It is also not recommended for individuals suffering from ongoing progressive diseases. It should not be administered to people who have severe reactions to the vaccine or its components.
Last revision date: 10 October 2012